Healthcare

Key data points: The market size in 2030 = $4.6 billion, growth forecast = 5.7% annually next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global dog vaccine market to 2030 by type (attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, and recombinant vaccine), age (below 6 months and above 6 months), end use (veterinary hospitals & clinics, pet owners, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2023 = $3.2 billion, growth forecast = 5% annually next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecast in Middle Eastern and North African active pharmaceutical ingredient (API) market to 2030 by synthesis type (synthetic chemical, biotech and biologics, plant extracts, fermentation, etc.), manufacturer type (captive API and merchant API), therapeutic area (cardiology, oncology, neurology, ophthalmology, orthopedics, pulmonology, etc.), product form (liquid API and powder API), molecule type (large molecule and small molecule), and drug type (branded, generic, etc.)

Key data points: The market size in 2030 = $10.5 billion, growth forecast = 6.1% annually next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global pet vaccine market to 2030 by type (canlane and feline), vaccination (canine family, core vaccines, and non-core vaccines), mode of administration (injectable vaccines and intranasal vaccines), application (dogs, cats, rabbits, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $19.5 billion, growth forecast = 16.8% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global medical cannabis market to 2030 by product type (buds/marijuana flower and cannabis extracts), application (chronic pain, mental disorders, cancer, and others), end use (pharmaceutical and research & development centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $6.1 billion, growth forecast = 7.2% annually next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global drug discovery outsourcing market to 2030 by drug type (small molecules and large molecules), workflow (target identification & screening, target validation & functional informatics, lead identification & candidate optimization, preclinical development, and other associated workflow), therapeutic area (cardiovascular, central nervous system (CNS), gastrointestinal, hematology, respiratory system, infectious disease, oncology, immunology, and others), end use (pharmaceutical and biotechnology companies, academic institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $6.9 billion, growth forecast = 4.1% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global livestock vaccine market to 2030 by product type (bovine vaccine, poultry vaccine, porcine vaccine, and others), technology (live attenuated vaccine, inactivated vaccine, toxoid vaccine, recombinant vaccine, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunities and forecast in the global gastrointestinal drug market to 2027 by drug class (acid neutralizers, antidiarrheal and laxatives, antiemetic and antinauseants, anti-inflammatory drugs, biologics, others (antispasmodic etc.)), route of administration (oral, intravenous, rectal), application (gastro-esophageal reflux disease, inflammatory bowel disease, irritable bowel syndrome), distribution channel (hospital pharmacies, retail pharmacies, online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $22.7 billion, growth forecast = 8.5% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global toxicology drug screening market to 2030 by technology (high-throughput screening, genomics, transcriptomics, toxicogenomics, and molecular screening), type (cardiovascular disease drug screening, obesity drug screening, diabetes drug screening, and others), test type (acute systemic toxicity, dermal toxicity, carcinogenicity, ocular toxicity, genotoxicity, neurotoxicity, and organ-specific toxicity), end use (hospitals and trauma centers, forensic laboratories, diagnostic laboratories, rehabilitation centers, and pharmaceutical & biotechnology companies), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $7.5 billion, growth forecast = 4.5% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global toxoid vaccine market to 2030 by vaccine type (diphtheria, tetanus, and pertussis (DTaP), diphtheria and tetanus (DT), tetanus, diphtheria, and pertussis (TDaP), and others), end use (hospitals, specialty center, governments organization, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunities and forecast in the global nuclear medicine/radiopharmaceutical market to 2024 by product type (diagnostic nuclear medicine/radiopharmaceutical (SPECT radiopharmaceutical, PET radiopharmaceutical), and therapeutic nuclear medicine/radiopharmaceutical (beta emitters, alpha emitters and brachytherapy), application (Cardiology, lymphoma, thyroid, oncology, neurology, bone metastasis, endocrine tumors), end user (hospitals and diagnostic centers, and research institutes), and region (North America, Asia-Pacific, Europe, Rest of the World(ROW)).

Trends, opportunities and forecast in the global injectable drug delivery market to 2024 by product type (devices and formulations), by formulation (ampules, vials, cartridges, and bottles),therapeutic application ( auto-immune diseases, hormonal disorders, orphan diseases, oncology and others), usage pattern (curative care, immunization and others), site of administration (skin, circulatory/ musculoskeletal, organs, and central nervous system), distribution channel (hospitals, and retail pharmacy stores), facility of use (hospitals & clinics, and home care settings), and region (North America, Europe, Asia-Pacific, and Rest of the World (ROW))

Key data points: The market size in 2030 = $979.0 million, growth forecast = 9.4% annually next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global citicoline supplement market to 2030 by indication (dementia, Alzheimer's disease, glaucoma, head trauma cases, cerebral ischemic stroke, cognitive impairment, attention deficit-hyperactive disorder (ADHD), and others), route of administration (oral, intravenous, intramuscular, and drops), form (citicoline base and sodium citicoline), distribution channel (retail pharmacies/drug stores, hospital pharmacies, specialty stores, online sales, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2035 = $32.1 billion, growth forecast = 9.7% annually for the next 8 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in thin film drug market to 2035 by type (transdermal film, oral thin film, and others), application (hospitals, drugstores, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunities and forecast in this market to 2017 by various segment and region (North America, Europe, Asia Pacific, Rest of the World)

Key data points: The market size in 2035 = $3.5 billion, growth forecast = 4.2% annually for the next 8 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in isoxazoline drug market to 2035 by type (fluralaner, afoxolaner, sarolaner, lotilaner, and others), application (dog, cat, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2035 = $1214 million, growth forecast = 4.4% annually for the next 8 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in difluprednate drug market to 2035 by type (patented drug and generic drug), application (hospital, drugs store, and online), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2035 = $2 billion, growth forecast = 6.2% annually for the next 8 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in rhinosinusitis drug market to 2035 by type (antibiotics, corticosteroids, decongestants, and others), application (acute sinusitis and chronic sinusitis), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2035 = $2348.5 million, growth forecast = 24.6% annually for the next 8 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in AR PROTAC drug market to 2035 by type (oral, topical, and others), product (CRBN, VHL, and others), application (prostate cancers and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2035 = $3.0 billion, growth forecast = 7.3% annually for the next 8 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in cognition supplement market to 2035 by product type (natural molecules, herbal extracts, vitamins & minerals, and others), form (capsules & tablets, powders, and gummies & chewables), distribution channel (supermarkets/hypermarkets, pharmacies/drug stores, online retail stores, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2035 = $14 billion, growth forecast = 6.1% annually for the next 8 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in muscle relaxant drug market to 2035 by type (centrally acting muscle relaxants and peripherally acting muscle relaxants), drug class (benzodiazepine derivative, non-benzodiazepine relaxant, depolarizing blocker, and non-depolarizing blocker), route of administration (oral, intravenous injection, and intramuscular injection), application (hospital pharmacy, retail pharmacy, and online pharmacy), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2035 = $8.5 billion, growth forecast = 8.8% annually for the next 8 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in MET inhibitor drug market to 2035 by type (C-met biological inhibitors, small molecule C-MET inhibitors, C-met antagonist antibodies, HGF antagonist antibodies, and kringle variant antagonists), application (hospital pharmacies, retail pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2035 = $3 billion, growth forecast = 4.4% annually for the next 8 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in drug label market to 2035 by type (paper label, plastic label, composite material label, and special material label), application (pharmaceutical factory, hospital, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 5.2% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in implantable ophthalmic drug market to 2031 by type (vitreous implant type, lacrimal gland implant type, micropump implantable type, and others), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 8% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in modified NSAID market to 2031 by type (COX-2 selective inhibitors, NO-NSAIDs, and others), product (acute pain management, chronic inflammation, and others), application (hospital clinical department, sports medicine, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 7.5% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in motherwort drug market to 2031 by type (injection, capsule, and others), application (hospitals, clinics, retail pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 6.5% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in pelvic cancer drug market to 2031 by type (kidney cancer, uterus cancer, and cervical cancer), application (chemotherapy, radiation therapy, and targeted therapy), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 8.5% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in iloprost drug market to 2031 by type (inhaled and intravenous), application (hospital and clinic), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 6.5% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in fibrinogen concentrate market to 2031 by source (human plasma-derived concentrates and recombinant / synthetic analogues), form (lyophilized powder vials and ready-to-use liquid formulations), application (congenital fibrinogen deficiency, trauma & surgery-related hemorrhage, obstetric & gynecological bleeding, and others), end use (hospitals, specialty clinics & hemophilia centers, and military & emergency medical services), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 6.8% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in osteogenic sarcoma drug market to 2031 by type (chemotherapy drugs, targeted therapy drugs, immunotherapy drugs, and supportive care drugs), application (high-grade osteogenic sarcoma, intermediate-grade osteogenic sarcoma, and low-grade osteogenic sarcoma), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 8.5% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in dydrogesterone drug market to 2031 by type (dydrogesterone and dydrogesterone+estradiol compound), application (infertility, gynecological diseases, and threatened abortion), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 3.2% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in antibiotic drug market to 2031 by type (oral, injection, and others), drug (b-lactams, tetracyclines, macrolides, aminoglycosides, peptides, quinolones, and others), application (hospitals, retail pharmacy, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 3.3% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in dermatology OTC medication market to 2031 by type (external use and oral), application (hospital, drug store, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 19.4% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in siRNA drug market to 2031 by delivery method (nanoparticles, lipid-based, polymer-based, and others), application (oncology, cardiovascular, respiratory, neurological, infectious diseases, and others), end use (hospitals, research institutes, pharmaceutical & biotechnology companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 3.1% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in neuromyelitis optica drug market to 2031 by type (glucocorticoids, immunotherapies, and others), application (acute attack and remission prophylactic treatment), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 30.1% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in microbiome drug market to 2031 by type (oral dosage form and enteric capsules), application (gastrointestinal disorders, autoimmune disorders, diabetes, cancer, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 11.9% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in anti-aging drug market to 2031 by type (dermal fillers, botulinum toxin, and others), application (hospital, beauty parlor, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 9.2% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in non-viral drug delivery market to 2031 by technology (nanoparticle drug delivery systems, hydrogel systems, microneedle systems, polymeric micelles, liposomes, and others), application (oncology, cardiovascular diseases, neurological diseases, infectious diseases, immunotherapy, genetic disorders, ophthalmology, and diabetes), end use (hospitals, specialty clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 14% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in next generation drug conjugate market to 2031 by type of conjugate (peptide-radionuclide conjugate, ligand mediated RNAi conjugate, ligand conjugated anti sense medicine, and peptide drug conjugate), type of targeting ligand (amino sugar, peptide, and lipids), type of therapy (monotherapy and combination therapy), type of payload (radionuclide, drugs, antisense oligonucleotide, and si-RNA), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 5.3% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunity and forecast in shockwave therapy machine market to 2031 by type (table-top/portable type and hand-push type), application (orthopedics, urology, sports medicine and rehab, pain department, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 4.1% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in drug screening market to 2031 by product type (instruments, rapid testing devices, consumables, services, and others), sample type (urine samples, breath samples, oral fluid samples, hair samples, and others), end use (hospitals, criminal justice & law enforcement agencies, workplaces, drug treatment centers, individual users, pain management centers, schools & colleges, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 6.9% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in collagen & ha-based biomaterial market to 2031 by material type (collagen and hyaluronic acid), source (animal derived and recombinant), application (aesthetics, drug delivery, ophthalmology, orthopedics, and wound care), end use (aesthetic clinics, ambulatory surgical centers, hospitals, and research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 4.1% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in transplant immunosuppressive drug market to 2031 by type (induction drugs, maintenance drugs, and anti-rejection drugs), transplant type (tissue transplantation, organ transplantation, kidney transplantation, liver transplantation, heart transplantation, lung transplantation, pancreas transplantation, and others), drug class (calcineurin inhibitors, mTOR inhibitors, antiproliferative agents, monoclonal antibodies, polyclonal antibodies, corticosteroids, and others), end use (hospitals, transplant centers, specialty clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 12.1% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in osimertinib drug market to 2031 by product type (tablets, capsules, and others), distribution channel (hospital pharmacies, retail pharmacies, online pharmacies, and others), application (non-small cell lung cancer and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2031 = $5.3 billion, growth forecast = 8.5% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global omega 3 prescription drug market to 2031 by drug (vascepa, lovaza, and others), distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy), application (hypertriglyceridemia, high cholesterol, inflammatory bowel disease, rheumatoid arthritis, mental health conditions, neurodevelopmental disorders, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2031 = $20.2 billion, growth forecast = 10.3% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global lysosomal storage disorder drug market to 2031 by type (enzyme replacement therapy, stem cell therapy, substrate reduction therapy, and others), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 5.7% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global janus kinases inhibitor drug market to 2031 by type (injectable and oral), application (oncology, musculoskeletal, gastroenterology, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 4.9% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global intestinal ascariasis medicine market to 2031 by type (painkiller, piperazine citrate, complication treatment drug, and others), application (patients with ulcer disease, complication treatment, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2031 = $6.1 billion, growth forecast = 10.2% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global in-silico drug discovery market to 2031 by type (software as a service, consultancy as a service, and software), target therapeutic area (human immunodeficiency virus (HIV), infectious diseases, metabolic disorders, mental disorders, musculoskeletal disorders, neurological disorders, oncological disorders, respiratory disorders, and others), workflow (discovery, target identification, reverse docking, lead discovery, pharmacophore, and others), end use (contract research organizations, pharmaceutical industry, academic & research institutes, and others), and region

Key data points: The market size in 2031 = $5.2 billion, growth forecast = 12.4% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global psychedelic drug market to 2031 by drug type (ketamine, psilocybin, and others), application (mental health, abuse disorder, and others), end use (hospitals, mental health center, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 8.1% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunity and forecast in sustained-release medicine market to 2031 by type (original ground medicine and generic medicine), application (hospital, drugstore, and other), and region (North America, Europe, Asia Pacific, and the Rest of the World)